PATENT CLAIM ANALYSIS

Application Number: 16108886
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "717000"]

Abstract:
The present invention provides compositions and methods for the dietary management of nephrolithiasis and hypocitraturia through the oral administration of multiple alkali salts including sodium bicarbonate, potassium citrate and/or magnesium citrate. Also provided are kits including compositions for the dietary management of nephrolithiasis and hypocitraturia.

Claim (Index 13):
A composition comprising:\n about 1 to 8 mmol/L sodium bicarbonate; about 0.8 to 3 mmol/L potassium citrate; about 0.6 to 2 mmol/L magnesium citrate; and about 400 to 1000 mg/L erythritol, wherein a pH of the composition is 3.3-8.0.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15681703', '15897344', '15062509', '14211645', '11673497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6862549178168054
- 35 USC 102 Novelty (BERT): 0.5012132310287564
- Combined Prediction Score: 0.6677507491380005
- Mean Citation Score: 238.008684
- Max Citation Score: 246.66788
- Similarity Product: 187.9303345492506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test